Sionna Therapeutics (SION) Non Operating Income (2024 - 2026)
Quarterly results put Non Operating Income at $2.8 million for Q1 2026, down 11.24% from a year ago — trailing twelve months through Mar 2026 was $13.4 million (up 24.31% YoY), and the annual figure for FY2025 was $13.7 million, up 54.65%.
Sionna Therapeutics has reported Non Operating Income over the past 3 years, most recently at $2.8 million for Q1 2026.
- Non Operating Income reached $2.8 million in Q1 2026 per SION's latest filing, down from $3.2 million in the prior quarter.
- Across five years, Non Operating Income topped out at $3.8 million in Q2 2025 and bottomed at $1.3 million in Q1 2024.
- Median Non Operating Income over the past 3 years was $2.8 million (2026), compared with a mean of $2.8 million.
- The largest annual shift saw Non Operating Income soared 144.38% in 2025 before it fell 11.24% in 2026.
- Over 3 years, Non Operating Income stood at $2.3 million in 2024, then soared by 38.82% to $3.2 million in 2025, then dropped by 11.1% to $2.8 million in 2026.
- Business Quant data shows Non Operating Income for SION at $2.8 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 201.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 2.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.82 Mn |
| Dec 31, 2025 | 3.17 Mn |
| Sep 30, 2025 | 3.53 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Mar 31, 2025 | 3.18 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 2.74 Mn |
| Mar 31, 2024 | 1.30 Mn |